Supernus Pharmaceuticals
SUPN
SUPN
297 hedge funds and large institutions have $1.98B invested in Supernus Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 100 increasing their positions, 108 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.34% less ownership
Funds ownership: 100.27% → 96.94% (-3.3%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
46% less call options, than puts
Call options by funds: $2.73M | Put options by funds: $5.04M
Holders
297
Holding in Top 10
3
Calls
$2.73M
Puts
$5.04M
Top Buyers
| 1 | +$9.58M | |
| 2 | +$7.39M | |
| 3 | +$7.32M | |
| 4 |
JP Morgan Chase
New York
|
+$6.85M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.29M |
Top Sellers
| 1 | -$19M | |
| 2 | -$17.6M | |
| 3 | -$12.7M | |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$9.71M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8.28M |